These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7734425)

  • 1. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
    Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
    Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
    Mongini PK; Highet PF; Inman JK
    J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.
    Rudich SM; Roux KH; Winchester RJ; Mongini PK
    J Exp Med; 1988 Jul; 168(1):247-66. PubMed ID: 2456368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands.
    Mongini PK; Blessinger CA; Dalton JP
    J Immunol; 1991 Mar; 146(6):1791-800. PubMed ID: 2005379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation by cross-linked B cell-membrane IgM.
    Ohishi K; Kanoh M; Shinomiya H; Hitsumoto Y; Utsumi S
    J Immunol; 1995 Apr; 154(7):3173-9. PubMed ID: 7897206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
    Mongini PK; Blessinger C; Posnett DN; Rudich SM
    J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane IgM-stimulated human B lymphocytes succumb to activation-related apoptosis at a G1-->S transition: influence of ligand affinity and valency.
    Mongini PK; Vilensky MA; Highet PF; Inman JK
    Cell Immunol; 1998 Sep; 188(2):137-50. PubMed ID: 9756644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).
    Mongini PK; Vilensky MA; Highet PF; Inman JK
    J Immunol; 1997 Oct; 159(8):3782-91. PubMed ID: 9378965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.
    Cragg MS; Zhang L; French RR; Glennie MJ
    Br J Cancer; 1999 Feb; 79(5-6):850-7. PubMed ID: 10070880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
    Mongini PK; Blessinger CA; Highet PF; Inman JK
    J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ligand-induced membrane IgM association with the cytoskeletal matrix of B cells is not mediated through the Ig alpha beta heterodimer.
    Hartwig JH; Jugloff LS; De Groot NJ; Grupp SA; Jongstra-Bilen J
    J Immunol; 1995 Oct; 155(8):3769-79. PubMed ID: 7561081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activation.
    Takahama Y; Ono S; Ishihara K; Muramatsu M; Hamaoka T
    Eur J Immunol; 1989 Dec; 19(12):2227-35. PubMed ID: 2558020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies.
    Subbarao B; Mosier DE
    J Exp Med; 1984 Jun; 159(6):1796-801. PubMed ID: 6427385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
    Cambier JC; Monroe JG
    J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.
    Fan Z; Lu Y; Wu X; Mendelsohn J
    J Biol Chem; 1994 Nov; 269(44):27595-602. PubMed ID: 7961676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling.
    van Horssen M; Loman S; Rijkers GT; Boom SE; Bloem AC
    Eur J Immunol; 1995 Jan; 25(1):154-8. PubMed ID: 7843226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.